Nuformix (LON:NFX) Stock Price Down 13.7%

Nuformix plc (LON:NFX)’s share price was down 13.7% during mid-day trading on Wednesday . The company traded as low as GBX 0.15 ($0.00) and last traded at GBX 0.15 ($0.00). Approximately 5,700,000 shares changed hands during trading, an increase of 132% from the average daily volume of 2,452,163 shares. The stock had previously closed at GBX 0.18 ($0.00).

Nuformix Price Performance

The firm has a market cap of £1.47 million, a PE ratio of -1.63 and a beta of 0.28. The stock’s fifty day moving average price is GBX 0.19 and its 200-day moving average price is GBX 0.24. The company has a debt-to-equity ratio of 1.17, a current ratio of 1.51 and a quick ratio of 3.35.

Nuformix Company Profile

Nuformix plc operates in the field of pharmaceutical development for treating fibrosis and oncology through drug repurposing in the United Kingdom. It offers NXP001, which has completed Phase 1 for use in oncology supportive care. The company is also developing NXP004, a novel form of Olaparib, which is in the IP generation phase for treating oncology; and NXP002 that is in pre-clinical stage for the treatment of idiopathic pulmonary fibrosis.